SlideShare uma empresa Scribd logo
1 de 24
PRESENTED  BY: PARTH  DHANANI  (10BPW618)     B.Pharm.Hons.   BATCH  E
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
 
INVESTIGATION DAY 1 DAY 2 Hb 6.3 8.5 TC 26,200 26,000 DC 68/17/1/12/2 73/20/2/5/0 PC  ↓se 82,000 1,66,000 PT  ↑se  Total Control 24 sec 13.2 sec --- RBS 120 mg/dL (75-115mg/dL) --- Urea ↑se 193.47 (10-20mg/dL)  --- Creatinine  ↑se 8.88  (<1.5mg/dL) --- Sodium 135.26 142.37 Potassium 4.7 4.1 S.Bilirubin ↑se 1.41 (0.3-1mg/dL) --- SOPT  ↑se 138.5 (0-35U/L) --- S.Ammonia  39.59 ---
INVESTIGATION DAY 1  DAY  2 LDH ↑se 2835 (14-26%) --- --- pH ↓se  (7.38-7.44)  7.21 --- pCO2 ↑se (35-45mmhg) 52 --- PO2  ↑se (80-100mmhg) 67 --- Bicarbonate ↓se  (20-30mE/L) 11 ---
[object Object],X-RAY ,[object Object],[object Object],USG (Abdomen) ,[object Object],CT SCAN(Brain)
[object Object],[object Object],[object Object],[object Object],[object Object]
DRUG DOSE ROA DURATION GENERIC NAME D1 D2 Inj. Pipzo 4.5 mg in 100ccNS i.v. 12hrly Piperacillin+tazobactam √ √ Inj. Metrogyl  100ml i.v. 8hrly Metronidazole √ √ Inj. Pantodac  40mg i.v. OD Pantoprazole  √ √ Inj. Levepil 500mg in 100ccNS i.v. 8hrly Levetiracetam √ √ Inj. Lasix 2amp i.v.  BD Furosemide √ √ Inj. FFP 250ml i.v. 8hrly Fresh frozen plasma √ √ Inj. Dopamine 2@ in 50ccNS i.v. 6hrly Dopamine √ √ Inj. Febrinil 1@ i.v. sos Paracetamol √ √ Inj. Falcigo 60mg i.v. OD Artesunate √ √ Inj. D25% 500ml i.v. 10ml/hr Dextrose √ √ Inj. Sodium bicarbonate (0.6*wt*HCO3 def.) 0.6*48*9 = 259.2mEq i.v. 13@ straight & 13@ 6hrly Bicarbonate √ √
[object Object],[object Object],[object Object],DRUG DOSE ROA DURATION GENERIC NAME D1 D2 Inj. Duphalac 15ml i.v. 8hrly Lactulose √ √ Inj. Vit K1 1@ in 100ccNS i.v. OD Vit K1 √ √ Inj. Norad 2@ in 50ccNS i.v. 6hrly Nor adrenaline --- √ Creatine Clearance Dose Dose interval 20-80 4/0.5 8 <20 4/0.5 12
DRUGS INTERACTIONS MANAGEMENT lactulose ↔ Artesunate ( moderate) Electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia. Electrolyte disturbances including hypokalemia and hypomagnesemia. The recommended dosage and duration of use should not be exceeded. Electrolye supplements needed to be administered. lumefantrine ↔ food (moderate) Coadministration with grapefruit juice may increase the plasma concentrations of artemethe. The mechanism is decreased clearance due to inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  Avoid the consumption of grapefruits and grapefruit juice. To ensure maximal oral absorption, artemether-lumefantrine should be taken with food. Inadequate food intake can increase the risk for recrudescence of malaria.
DRUGS INTERACTIONS MANAGEMENT furosemide ↔ lactulose (Moderate) Potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes In general, laxatives should only be used on a short-term, intermittent basis in recommended dosages. Contact physician if they experience signs and symptoms of fluid and electrolyte depletion such as dizziness, lightheadedness, dry mouth, thirst, fatigue, weakness, decreased urination, postural hypotension, and tachycardia.
[object Object],[object Object],[object Object],[object Object]
THANK  YOU

Mais conteúdo relacionado

Mais procurados

Abruptio placenta case present
Abruptio placenta case presentAbruptio placenta case present
Abruptio placenta case presentDR MUKESH SAH
 
POST PARTUM HEMORRHAGE(PPH)
POST PARTUM HEMORRHAGE(PPH)POST PARTUM HEMORRHAGE(PPH)
POST PARTUM HEMORRHAGE(PPH)PRANATI PATRA
 
post partum haemorrhage
post partum haemorrhagepost partum haemorrhage
post partum haemorrhagefarranajwa
 
Antepartum hemorrhage
Antepartum hemorrhageAntepartum hemorrhage
Antepartum hemorrhageSnigdha Gupta
 
Management of Post-partum hemorrhage (PPH)
Management of Post-partum hemorrhage (PPH)Management of Post-partum hemorrhage (PPH)
Management of Post-partum hemorrhage (PPH)Sandesh Kamdi
 
Magnesium Sulphate in Eclampsia
Magnesium Sulphate in EclampsiaMagnesium Sulphate in Eclampsia
Magnesium Sulphate in EclampsiaAde Wijaya
 
PREGNANCY INDUCED HYPERTENSION
PREGNANCY INDUCED HYPERTENSIONPREGNANCY INDUCED HYPERTENSION
PREGNANCY INDUCED HYPERTENSIONsiti hamidah
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitusJasmi Manu
 
Case presentation of previous two cesarean section
Case presentation of previous two cesarean sectionCase presentation of previous two cesarean section
Case presentation of previous two cesarean sectionvaibhavsharma19871987
 
seminar on normal newborn...
seminar on normal newborn...seminar on normal newborn...
seminar on normal newborn...Reshma Kadam
 
Case of birth asphyxia
Case of birth asphyxiaCase of birth asphyxia
Case of birth asphyxiafawad23
 

Mais procurados (20)

Oligohydramnios
OligohydramniosOligohydramnios
Oligohydramnios
 
PRE -ECLAMPSIA
 PRE -ECLAMPSIA PRE -ECLAMPSIA
PRE -ECLAMPSIA
 
Abruptio placenta case present
Abruptio placenta case presentAbruptio placenta case present
Abruptio placenta case present
 
POST PARTUM HEMORRHAGE(PPH)
POST PARTUM HEMORRHAGE(PPH)POST PARTUM HEMORRHAGE(PPH)
POST PARTUM HEMORRHAGE(PPH)
 
post partum haemorrhage
post partum haemorrhagepost partum haemorrhage
post partum haemorrhage
 
Eclampsia
Eclampsia Eclampsia
Eclampsia
 
eclampsia presentation
eclampsia presentationeclampsia presentation
eclampsia presentation
 
Antepartum hemorrhage
Antepartum hemorrhageAntepartum hemorrhage
Antepartum hemorrhage
 
Management of Post-partum hemorrhage (PPH)
Management of Post-partum hemorrhage (PPH)Management of Post-partum hemorrhage (PPH)
Management of Post-partum hemorrhage (PPH)
 
pre eclampsia
pre eclampsiapre eclampsia
pre eclampsia
 
Magnesium Sulphate in Eclampsia
Magnesium Sulphate in EclampsiaMagnesium Sulphate in Eclampsia
Magnesium Sulphate in Eclampsia
 
PREGNANCY INDUCED HYPERTENSION
PREGNANCY INDUCED HYPERTENSIONPREGNANCY INDUCED HYPERTENSION
PREGNANCY INDUCED HYPERTENSION
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
Postpartum hemorrhage
Postpartum hemorrhage Postpartum hemorrhage
Postpartum hemorrhage
 
Cord Prolapse
Cord ProlapseCord Prolapse
Cord Prolapse
 
Case presentation of previous two cesarean section
Case presentation of previous two cesarean sectionCase presentation of previous two cesarean section
Case presentation of previous two cesarean section
 
seminar on normal newborn...
seminar on normal newborn...seminar on normal newborn...
seminar on normal newborn...
 
Case of birth asphyxia
Case of birth asphyxiaCase of birth asphyxia
Case of birth asphyxia
 
Pih
PihPih
Pih
 
POLYHYDRAMINOS
POLYHYDRAMINOSPOLYHYDRAMINOS
POLYHYDRAMINOS
 

Semelhante a Case Study of Eclampsia

Pre eclampsia; eclampsia
Pre eclampsia; eclampsiaPre eclampsia; eclampsia
Pre eclampsia; eclampsiaEddo Adams
 
Pregnancy Induced Hypertension & Preeclampsia
Pregnancy Induced Hypertension &  PreeclampsiaPregnancy Induced Hypertension &  Preeclampsia
Pregnancy Induced Hypertension & PreeclampsiaAditya Joshi
 
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
P R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O NP R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O N
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O NDr. Shaheer Haider
 
Eclampsia – neurological aspects
Eclampsia –           neurological aspectsEclampsia –           neurological aspects
Eclampsia – neurological aspectsNeurologyKota
 
Preeclampsia n eclamsia moumita
Preeclampsia n eclamsia moumitaPreeclampsia n eclamsia moumita
Preeclampsia n eclamsia moumitaMOUMITA MANNA
 
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.pptimnetuy
 
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.pptOgunsina1
 
Preeclampsia in pregnancy etiopathogenesis and management
Preeclampsia in pregnancy  etiopathogenesis and management Preeclampsia in pregnancy  etiopathogenesis and management
Preeclampsia in pregnancy etiopathogenesis and management Deepti Daswani
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancysnigdhanaskar1
 
Figeroa pih
Figeroa   pihFigeroa   pih
Figeroa pihfelling
 
H:\Gestational Hypertension Capp Moms Mess 2[1]
H:\Gestational Hypertension Capp Moms Mess 2[1]H:\Gestational Hypertension Capp Moms Mess 2[1]
H:\Gestational Hypertension Capp Moms Mess 2[1]cslonern
 

Semelhante a Case Study of Eclampsia (20)

Pre eclampsia; eclampsia
Pre eclampsia; eclampsiaPre eclampsia; eclampsia
Pre eclampsia; eclampsia
 
preeclampsia.pptx
preeclampsia.pptxpreeclampsia.pptx
preeclampsia.pptx
 
Pregnancy Induced Hypertension & Preeclampsia
Pregnancy Induced Hypertension &  PreeclampsiaPregnancy Induced Hypertension &  Preeclampsia
Pregnancy Induced Hypertension & Preeclampsia
 
Pregnancy and Renal Disease
Pregnancy and Renal DiseasePregnancy and Renal Disease
Pregnancy and Renal Disease
 
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
P R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O NP R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O N
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
 
Eclampsia – neurological aspects
Eclampsia –           neurological aspectsEclampsia –           neurological aspects
Eclampsia – neurological aspects
 
Pregnancy hypertension
Pregnancy hypertensionPregnancy hypertension
Pregnancy hypertension
 
Preeclampsia n eclamsia moumita
Preeclampsia n eclamsia moumitaPreeclampsia n eclamsia moumita
Preeclampsia n eclamsia moumita
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
 
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
07. HYPERTENSIVE DISORDERS IN PREGNANCY.ppt
 
Preeclampsia.pdf
Preeclampsia.pdfPreeclampsia.pdf
Preeclampsia.pdf
 
Preeclampsia in pregnancy etiopathogenesis and management
Preeclampsia in pregnancy  etiopathogenesis and management Preeclampsia in pregnancy  etiopathogenesis and management
Preeclampsia in pregnancy etiopathogenesis and management
 
Hypertensive disorders in pregnancy
Hypertensive disorders in pregnancyHypertensive disorders in pregnancy
Hypertensive disorders in pregnancy
 
Pih
PihPih
Pih
 
Figeroa pih
Figeroa   pihFigeroa   pih
Figeroa pih
 
High Risk Pregnancy
High Risk PregnancyHigh Risk Pregnancy
High Risk Pregnancy
 
H:\Gestational Hypertension Capp Moms Mess 2[1]
H:\Gestational Hypertension Capp Moms Mess 2[1]H:\Gestational Hypertension Capp Moms Mess 2[1]
H:\Gestational Hypertension Capp Moms Mess 2[1]
 
Pre eclampsia
Pre eclampsiaPre eclampsia
Pre eclampsia
 
A case of Recurrent Pancreatitis
A case of Recurrent PancreatitisA case of Recurrent Pancreatitis
A case of Recurrent Pancreatitis
 

Case Study of Eclampsia

  • 1. PRESENTED BY: PARTH DHANANI (10BPW618) B.Pharm.Hons. BATCH E
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.  
  • 13.  
  • 14.  
  • 15. INVESTIGATION DAY 1 DAY 2 Hb 6.3 8.5 TC 26,200 26,000 DC 68/17/1/12/2 73/20/2/5/0 PC ↓se 82,000 1,66,000 PT ↑se Total Control 24 sec 13.2 sec --- RBS 120 mg/dL (75-115mg/dL) --- Urea ↑se 193.47 (10-20mg/dL) --- Creatinine ↑se 8.88 (<1.5mg/dL) --- Sodium 135.26 142.37 Potassium 4.7 4.1 S.Bilirubin ↑se 1.41 (0.3-1mg/dL) --- SOPT ↑se 138.5 (0-35U/L) --- S.Ammonia 39.59 ---
  • 16. INVESTIGATION DAY 1 DAY 2 LDH ↑se 2835 (14-26%) --- --- pH ↓se (7.38-7.44) 7.21 --- pCO2 ↑se (35-45mmhg) 52 --- PO2 ↑se (80-100mmhg) 67 --- Bicarbonate ↓se (20-30mE/L) 11 ---
  • 17.
  • 18.
  • 19. DRUG DOSE ROA DURATION GENERIC NAME D1 D2 Inj. Pipzo 4.5 mg in 100ccNS i.v. 12hrly Piperacillin+tazobactam √ √ Inj. Metrogyl 100ml i.v. 8hrly Metronidazole √ √ Inj. Pantodac 40mg i.v. OD Pantoprazole √ √ Inj. Levepil 500mg in 100ccNS i.v. 8hrly Levetiracetam √ √ Inj. Lasix 2amp i.v. BD Furosemide √ √ Inj. FFP 250ml i.v. 8hrly Fresh frozen plasma √ √ Inj. Dopamine 2@ in 50ccNS i.v. 6hrly Dopamine √ √ Inj. Febrinil 1@ i.v. sos Paracetamol √ √ Inj. Falcigo 60mg i.v. OD Artesunate √ √ Inj. D25% 500ml i.v. 10ml/hr Dextrose √ √ Inj. Sodium bicarbonate (0.6*wt*HCO3 def.) 0.6*48*9 = 259.2mEq i.v. 13@ straight & 13@ 6hrly Bicarbonate √ √
  • 20.
  • 21. DRUGS INTERACTIONS MANAGEMENT lactulose ↔ Artesunate ( moderate) Electrolyte loss and increase the risk of torsade de pointes ventricular arrhythmia. Electrolyte disturbances including hypokalemia and hypomagnesemia. The recommended dosage and duration of use should not be exceeded. Electrolye supplements needed to be administered. lumefantrine ↔ food (moderate) Coadministration with grapefruit juice may increase the plasma concentrations of artemethe. The mechanism is decreased clearance due to inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits. Avoid the consumption of grapefruits and grapefruit juice. To ensure maximal oral absorption, artemether-lumefantrine should be taken with food. Inadequate food intake can increase the risk for recrudescence of malaria.
  • 22. DRUGS INTERACTIONS MANAGEMENT furosemide ↔ lactulose (Moderate) Potentiate the pharmacologic effects of diuretics. Laxatives can cause significant losses of fluid and electrolytes In general, laxatives should only be used on a short-term, intermittent basis in recommended dosages. Contact physician if they experience signs and symptoms of fluid and electrolyte depletion such as dizziness, lightheadedness, dry mouth, thirst, fatigue, weakness, decreased urination, postural hypotension, and tachycardia.
  • 23.

Notas do Editor

  1. PATIENT’S DATA PATIENT NAME:XYZ ADDRESS: Ahmadabad AGE:59 years SEX: Male HEIGHT:5ft 6in WEIGHT:68kg DOA:20/06/2010 DOD:28/6/2010